Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits

Arthritis and Rheumatism

Volumn 50, Issue 10, 2004, Pages 3387-3391

  Motomura, Goro ^a   Yamamoto, Takuaki ^a,b   Miyanishi, Keita ^a   Jingushi, Seiya ^a   Iwamoto, Yukihide ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLPREDNISOLONE ACETATE; PROBUCOL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; WARFARIN;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD EXAMINATION; BONE MARROW CELL; BONE NECROSIS; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEONECROSIS; DRUG INDUCED DISEASE; FEMUR; HISTOPATHOLOGY; HUMERUS; INCIDENCE; LIPID BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTHROMBIN TIME; RABBIT; STATISTICAL ANALYSIS;

ADIPOCYTES; ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTICOAGULANTS; BONE MARROW; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; INJECTIONS, INTRAMUSCULAR; LIPIDS; MALE; METHYLPREDNISOLONE; OSTEONECROSIS; PROBUCOL; RABBITS; WARFARIN;

EID: 5644293137     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20517     Document Type: Article

References (14)

1. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am 1995;77:459-74.
2. Brinker MR, Rosenberg AG, Kull L, Galante JO. Primary total hip arthroplasty using noncemented porous-coated femoral components in patients with osteonecrosis of the femoral head. J Arthroplasty 1994;9:457-68.
3. Chiu KH, Shen WY, Ko CK, Chan KM. Osteonecrosis of the femoral head treated with cementless total hip arthroplasty: a comparison with other diagnoses. J Arthroplasty 1997;12:683-8.
4. Fisher DE. The role of fat embolism in the etiology of corticosteroid-induced avascular necrosis: clinical and experimental reults. Clin Orthop 1978;130:68-80.
5. Jones JP Jr. Intravascular coagulation and osteonecrosis. Clin Orthop 1992;277:41-53.
6. Yamamoto T, Irisa T, Sugioka Y, Sueishi K. Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum 1997;40:2055-64.
7. Irisa T, Yamamoto T, Miyanishi K, Yamashita A, Iwamoto Y, Sugioka Y, et al. Osteonecrosis induced by a single administration of low-dose lipopolysaccharide in rabbits. Bone 2001;28:641-9.
8. Miyanishi K, Yamamoto T, Irisa T, Yamashita A, Jingushi S, Noguchi Y, et al. Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis. Bone 2002;30:185-90.
9. Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop 2001;386:173-8.
10. Price PA, Williamson MK. Effects of warfarin on bone: studies on the vitamin K-dependent protein of rat bone. J Biol Chem 1981;256:12754-9.
11. Fujita M, Shirai K. A comparative study of the therapeutic effect of probucol and pravastatin on xanthelasma. J Dermatol 1996;23:598-602.
12. Miyanishi K, Yamamoto T, Irisa T, Yamashita A, Jingushi S, Noguchi Y, et al. A high low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a potential risk factor for corticosteroid-induced osteonecrosis in rabbits. Rheumatology (Oxford) 2001;40:196-201.
13. Asherson RA, Liote F, Page B, Meyer O, Buchanan N, Khamashta MA, et al. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 1993;20:284-8.
14. 2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype. Arthritis Rheum 2001;44:2870-8.